WallStSmart

Scienture Holdings, Inc. (SCNX)vsWellgistics Health, Inc. Common Stock (WGRX)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Wellgistics Health, Inc. Common Stock generates 3472% more annual revenue ($23.34M vs $653,390). WGRX leads profitability with a 0.0% profit margin vs 0.0%. SCNX earns a higher WallStSmart Score of 33/100 (F).

SCNX

Avoid

33

out of 100

Grade: F

Growth: 4.0Profit: 2.5Value: 8.3Quality: 5.0

WGRX

Avoid

30

out of 100

Grade: F

Growth: 2.7Profit: 2.5Value: 5.0Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

SCNXUndervalued (+91.2%)

Margin of Safety

+91.2%

Fair Value

$5.10

Current Price

$0.46

$4.64 discount

UndervaluedFair: $5.10Overvalued

Intrinsic value data unavailable for WGRX.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

SCNX2 strengths · Avg: 10.0/10
P/E RatioValuation
0.7x10/10

Attractively priced relative to earnings

Price/BookValuation
0.1x10/10

Reasonable price relative to book value

WGRX0 strengths · Avg: 0/10

No standout strengths identified

Areas to Watch

SCNX4 concerns · Avg: 3.0/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$19.69M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Return on EquityProfitability
-24.1%2/10

ROE of -24.1% — below average capital efficiency

WGRX4 concerns · Avg: 3.0/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$10.44M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Return on EquityProfitability
-9.3%2/10

ROE of -9.3% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : SCNX

The strongest argument for SCNX centers on P/E Ratio, Price/Book.

Bull Case : WGRX

WGRX has a balanced fundamental profile.

Bear Case : SCNX

The primary concerns for SCNX are EPS Growth, Market Cap, Profit Margin.

Bear Case : WGRX

The primary concerns for WGRX are EPS Growth, Market Cap, Profit Margin.

Key Dynamics to Monitor

SCNX is growing revenue faster at 8.1% — sustainability is the question.

SCNX generates stronger free cash flow (-3M), providing more financial flexibility.

Monitor PHARMACEUTICAL RETAILERS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

SCNX scores higher overall (33/100 vs 30/100). Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Scienture Holdings, Inc.

HEALTHCARE · PHARMACEUTICAL RETAILERS · USA

Scienture Holdings, Inc. (SCNX) is an innovative biotechnology company focused on developing cutting-edge therapeutic solutions for neurological disorders. With a robust drug development pipeline supported by advanced technology and a highly skilled research team, Scienture is committed to meeting unmet medical needs and improving patient outcomes. The company's strategic emphasis on scientific excellence, regulatory compliance, and collaborative partnerships positions it well for growth within the burgeoning healthcare sector, highlighting its potential to make significant contributions to global health advancements.

Wellgistics Health, Inc. Common Stock

HEALTHCARE · PHARMACEUTICAL RETAILERS · USA

Wellgistics Health, Inc. is a wholesaler and distributor of pharmaceutical products to pharmaceutical manufacturers and independent retail pharmacies in the United States. The company is headquartered in Tampa, Florida.

Want to dig deeper into these stocks?